YARW
Yarrow Bioscience Inc
22.30$
-5.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +407.0% | -6.2% | -5.5% | -12.1% | -12.2% | -15.7% | -20.7% | -19.2% | -16.5% | -14.2% | -8.8% | |
| – | +448.0% | -6.0% | -7.1% | -12.2% | -12.4% | -14.8% | -19.2% | -19.1% | -16.4% | -14.1% | -8.8% | |
| – | +98.2% | -37.6% | +54.9% | -45.0% | +22.5% | +41.6% | -21.8% | -12.3% | +24.2% | +2.5% | -6.9% | |
| – | +503.7% | -7.8% | -9.2% | -10.1% | -12.4% | -18.3% | -21.1% | -17.5% | -11.3% | -14.1% | -8.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.3% | -7.2% | +41.8% | +7.5% | +17.0% | -17.1% | -52.5% | -30.7% | -40.8% | -48.4% | +24.8% | |
| – | +16.9% | -8.1% | +69.6% | +7.7% | +17.0% | -17.1% | -52.5% | -30.7% | -40.8% | -48.4% | +24.8% | |
| – | – | +1.7% | +2.6% | +2.5% | -19.5% | -36.4% | -60.3% | – | – | – | – | |
| – | +131.7% | +68.5% | +61.6% | -11.7% | -32.1% | +30.6% | -60.0% | -15.3% | -13.0% | -74.9% | +135.2% | |
| – | +671.3% | -6.0% | -10.2% | -15.1% | -18.0% | -15.3% | -11.9% | -17.5% | -13.5% | -11.3% | -10.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +846.1% | +37.1% | +0.0% | +0.0% | +0.0% | +0.2% | +0.2% | +0.1% | -22.1% | +28.3% | +0.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.